NCT06588101

Brief Summary

There is a need to identify strategies that improve the conduct of clinical trials involving family members of intensive care unit (ICU) patients. The purpose of the present study is to evaluate recruitment and retention strategies for clinical trials involving family members of ICU patients. 4 strategies (2 recruitment and 2 retention) will be tested. Investigators will integrate the strategies into three existing studies that involve family members of ICU patients. Participants will be randomized using a 2x2 factorial design. The co-primary outcomes are recruitment percentage (participants enrolled/participants approached) and retention percentage (participants completing follow-up/participants enrolled).

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
160

participants targeted

Target at P75+ for not_applicable

Timeline
7mo left

Started May 2024

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress76%
May 2024Dec 2026

First Submitted

Initial submission to the registry

April 19, 2024

Completed
12 days until next milestone

Study Start

First participant enrolled

May 1, 2024

Completed
5 months until next milestone

First Posted

Study publicly available on registry

September 19, 2024

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2026

Completed
8 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2026

Expected
Last Updated

June 4, 2025

Status Verified

May 1, 2025

Enrollment Period

2 years

First QC Date

April 19, 2024

Last Update Submit

May 29, 2025

Conditions

Outcome Measures

Primary Outcomes (2)

  • Recruitment percentage

    Family member participants enrolled/ family member participants approached

    At enrolment

  • Retention percentage

    Family member participant completing follow-up/family member participants enrolled

    From enrolment until 6 month follow-up completion

Study Arms (4)

Both recruitment strategies

EXPERIMENTAL

Consent form with Infographic + Large compensation

Other: Written informed consent with infographicOther: Compensation

Neither recruitment strategy

NO INTERVENTION

Consent form + No compensation

One recruitment strategy - Infographic

EXPERIMENTAL

Consent form with Infographic + No compensation

Other: Written informed consent with infographic

One recruitment strategy - Compensation

EXPERIMENTAL

Consent form + Large compensation

Other: Compensation

Interventions

Potential participants are provided a visual infographic depicting the key elements of the written consent form in addition to the standard written consent form.

Both recruitment strategiesOne recruitment strategy - Infographic

Potential participants are provided an e-gift card to Amazon or Second Cup as a reward for completing the enrollment questionnaire.

Both recruitment strategiesOne recruitment strategy - Compensation

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Has family member admitted to an intensive care unit.
  • Expected hospital stay \> 48 hours
  • Able to participate in English or French

You may not qualify if:

  • Has another family member participating in the trial
  • Repeat admissions within the study period

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Jewish General Hospital

Montreal, Quebec, Canada

RECRUITING

MeSH Terms

Interventions

Compensation and Redress

Intervention Hierarchy (Ancestors)

EconomicsHealth Care Economics and OrganizationsJurisprudenceSocial Control, Formal

Study Officials

  • Michael J Goldfarb, MD, MSc

    Lady Davis Institute, McGill University, Jewish General Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
CARE PROVIDER, OUTCOMES ASSESSOR
Purpose
OTHER
Intervention Model
FACTORIAL
Model Details: 2x2 Design for randomization strategies 2x2 Desgin for retention strategies
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Attending Staff, Division of Cardiology

Study Record Dates

First Submitted

April 19, 2024

First Posted

September 19, 2024

Study Start

May 1, 2024

Primary Completion

April 30, 2026

Study Completion (Estimated)

December 31, 2026

Last Updated

June 4, 2025

Record last verified: 2025-05

Data Sharing

IPD Sharing
Will not share

Locations